Top Markets
#1 Songbird Songbird +11.52%
#2 pipedog pipedog +7.75%
#3 Collector Crypt Collector Crypt +6.31%
#4 Cryptopia Cryptopia +5.90%
#5 DAPPOS DAPPOS +4.59%
#6 OpenGradient OpenGradient +3.93%
#7 Moolah Moolah +3.64%
#8 Liquity Liquity +3.60%
#9 Pearl Pearl +3.36%
#10 Clearpool Clearpool +3.26%
Coin of the day
Songbird Songbird
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MedPlus Health Services Limited MedPlus Health Services Limited

MedPlus Health Services Limited

MEDPLUS
Kedudukan dalam Saham #10055
MedPlus Health Services Limited operates primarily as an Indian retailer of... MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Harga Saham
$7.46
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$896.69M
Perubahan (1 hari)
-1.74%
Perubahan (1 tahun)
-21.84%
Negara
IN
Perdagangan MedPlus Health Services Limited (MEDPLUS)

Kategori

Healthcare
Nisbah P/E bagi MedPlus Health Services Limited (MEDPLUS)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini MedPlus Health Services Limited, nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi MedPlus Health Services Limited dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 31.46 -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.